News

Filter

Current filters:

Gastro-intestinalsPfizer

1 to 9 of 19 results

Impax Labs confirms patent challenge to Pfizer/UCB's Toviaz

04-07-2013

US specialty drugmaker Impax Laboratories (Nasdaq: IPXL) yesterday confirmed that it has initiated a…

Gastro-intestinalsGenericsImpax LaboratoriesNorth AmericaPatentsPfizerToviazUCB

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Rhythm expands Series B financing to $33 Million, adding Pfizer Ventures as an investor

27-11-2012

Boston, USA-based biotech firm Rhythm Pharmaceuticals says it has raised an additional $8 million to…

BiotechnologyFinancialGastro-intestinalsIpsenPfizerResearchRhythm PharmaceuticalsRM-131

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan

10-09-2012

SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Pfizer RA drug candidate tofacitinib shows promise in ulcerative colitis

16-08-2012

Patients with moderately to severely active ulcerative colitis treated with drug behemoth Pfizer's (NYSE…

Gastro-intestinalsPfizerPharmaceuticalResearchtofacitinib

AstraZeneca to get $250 million-plus from OTC Nexium deal with Pfizer

15-08-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says it has entered into an agreement with Pfizer (NYSE:…

AstraZenecaFinancialGastro-intestinalsGlobalLicensingNexiumPfizerPharmaceutical

1 to 9 of 19 results

Back to top